Contact Us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right. 


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.


News and updates about Segue Therapeutics

STXPC selects a new Chief Scientific Officer (CSO).

David Coleman

Dr. Nick Dulin, as research investigator at the University of Chicago, has accepted the appointment of CSO for STXPC. Dr. Dulin is a leader in researching the mechanisms that are involved in fibrosis and discovering new drugs that block this pathological process. He will lead the team to complete preclinical animal studies and other IND-enabling studies for the repurposed drugs, positioned to enter clinical trials in the next year.